Viewing Study NCT02228850


Ignite Creation Date: 2025-12-24 @ 5:00 PM
Ignite Modification Date: 2026-06-08 @ 7:56 PM
Study NCT ID: NCT02228850
Status: COMPLETED
Last Update Posted: 2016-03-22
First Post: 2014-08-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Phenomenon Secondary to Systemic Sclerosis
Sponsor: NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module